Several types of medication can stop your period entirely, though none works like flipping a switch. Hormonal IUDs, injectable progestins, subdermal implants, continuous oral contraceptives, high-dose progestins, and GnRH-targeting drugs all achieve amenorrhea in a meaningful share of users, but the rates and timelines vary widely. The path to a completely suppressed period almost always involves an adjustment phase of irregular spotting or breakthrough bleeding before things quiet down.
Hormonal IUDs
The levonorgestrel-releasing intrauterine system (sold under brand names like Mirena and Liletta) is one of the most studied options for period suppression. It works locally, releasing a small amount of progestin directly into the uterus, which thins the uterine lining over time. The catch is that full suppression doesn’t happen quickly. A systematic review and meta-analysis found that almost no users experienced amenorrhea in the first 90 days after insertion. By months three through six, that number rose to about 8%, and roughly 18% of users had at least one 90-day stretch of no bleeding during the first year.1PubMed Central. Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis Another study reported similar numbers: amenorrhea rates of about 9% at six months and 17% at nine and twelve months.2PubMed. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use
That means the hormonal IUD is better understood as a method that dramatically lightens periods for most people rather than one that reliably stops them. Many users do eventually lose their period entirely, especially after the first year, but if complete suppression from the start is the goal, other methods may get there faster. The advantage of the IUD is its longevity and its low systemic hormone exposure, since the progestin stays mostly local rather than circulating through the bloodstream.
The Depo-Provera Injection
Depot medroxyprogesterone acetate, widely known as Depo-Provera, is an injectable progestin given every three months. It works by suppressing ovulation at a systemic level. Amenorrhea rates tend to climb with continued use: roughly half of users report no periods after a year of injections, and that proportion grows the longer someone stays on it. It’s one of the more reliable options for achieving full period cessation, and it doesn’t require daily adherence or a device insertion.
The tradeoff is that Depo-Provera carries a well-documented concern about bone mineral density. The effect appears to be duration-related and more pronounced in adolescents, though evidence shows that bone density recovers after stopping the injections.3PubMed Central. EFFECT OF ORAL CONTRACEPTIVES ON BONE MINERAL DENSITY This is one reason clinicians sometimes prefer other long-acting methods for very young users or people who anticipate using the injection for many years. The injection also has the longest delay in return to fertility among reversible contraceptives, which is worth knowing up front.
Subdermal Implants
The etonogestrel implant (Nexplanon) is a small rod inserted under the skin of the upper arm, effective for up to three years. Like the IUD, its effect on bleeding is variable. A study of adolescents found that about 29% were amenorrheic 12 months after placement.4PubMed. Amenorrhea in adolescents using the etonogestrel contraceptive implant That same research identified a couple of predictors: people with a higher body mass index and those who became amenorrheic within the first three months were more likely to stay that way at one year.
The implant’s unpredictability is its main drawback for period suppression. While about a third of users lose their period, another group experiences prolonged or irregular bleeding that can be more bothersome than their natural cycle. Ovarian hormones continue to fluctuate during implant use and still influence endometrial shedding, which partly explains the wide range of bleeding patterns.5PubMed. Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implants There’s no reliable way to predict before insertion which camp you’ll fall into.
Continuous Oral Contraceptives
Traditional combined oral contraceptive packs include 21 active pills followed by 7 placebo days, during which a withdrawal bleed occurs. That seven-day break was built into the original pill design for social and religious acceptability, not for any medical reason. Newer formulations take advantage of this by either shortening the placebo interval, extending the active phase, or eliminating the break altogether.6PubMed Central. Evaluation of extended and continuous use oral contraceptives
Extended-cycle pills like Seasonale provide 84 active days followed by 7 placebo days, reducing periods to about four per year. Continuous regimens, where you skip all placebo pills, aim for zero periods. In practice, breakthrough bleeding and spotting are common in the first few months of continuous use but tend to decrease with time. Success rates for complete amenorrhea vary by study, but many users find that after three to six months of continuous pills, bleeding episodes become rare or stop. A review of menstrual suppression options noted that most agents used for this purpose have increasing rates of amenorrhea over time, though irregular bleeding remains the most common limiting side effect.7PubMed Central. Menstrual suppression: current perspectives
One practical advantage of oral contraceptives is dose flexibility. If breakthrough bleeding occurs, some clinicians advise a brief three- or four-day hormone-free interval to allow a controlled withdrawal bleed, then resuming continuous pills. This strategy often “resets” the endometrium and reduces spotting going forward.
High-Dose Oral Progestins
Norethindrone acetate, a progestin-only pill, is sometimes prescribed at higher-than-contraceptive doses specifically to suppress menstruation. This approach is common in adolescent gynecology and for people who cannot take estrogen. The standard contraceptive dose is 0.35 mg, but menstrual suppression protocols often use 5 mg or more. People with obesity or heavy menstrual bleeding may need even higher doses to achieve full suppression.8PubMed. Norethindrone dosing for adequate menstrual suppression in adolescents
Compared to combined oral contraceptives, high-dose norethindrone acetate appears to cause fewer side effects in at least some clinical settings. A small study of patients hospitalized for acute abnormal uterine bleeding found that both norethindrone acetate and combined pills stopped bleeding in about 2.6 days on average, but the norethindrone group reported substantially fewer side effects.9PubMed. Norethindrone Acetate Versus Combined Oral Contraceptives in Patients With Acute Abnormal Uterine Bleeding High-dose progestins are particularly useful for people with contraindications to estrogen, including those with a history of blood clots, migraine with aura, or certain cardiovascular conditions.
GnRH Agonists and Antagonists
Gonadotropin-releasing hormone (GnRH) medications work upstream of the ovaries, essentially turning down the brain’s hormonal signals that drive the menstrual cycle. They come in two flavors. GnRH agonists (like leuprolide, sold as Lupron) initially cause a brief surge of hormones before shutting things down, which can temporarily worsen symptoms. GnRH antagonists (like elagolix and relugolix) skip that flare, blocking the receptor directly and suppressing hormone levels more quickly.10PubMed Central. Does timing matter when initiating elagolix in a natural menstrual cycle?
These drugs are among the most effective at stopping periods because they create a state of very low estrogen, similar to menopause. That potency is also their limitation: prolonged low estrogen leads to hot flashes, vaginal dryness, and bone loss. To counter this, newer formulations like relugolix combination therapy pair the GnRH antagonist with low-dose estrogen and progestin (“add-back therapy”) to maintain enough estrogen to protect bones and reduce side effects while still controlling symptoms from conditions like fibroids and endometriosis.11PubMed Central. Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis
GnRH medications are typically reserved for specific medical conditions rather than contraception or lifestyle-based suppression. Endometriosis, uterine fibroids, and precocious puberty are the most common indications. Cost can be a barrier, as these drugs tend to be significantly more expensive than other hormonal options.
Testosterone in Gender-Affirming Care
For transgender men and transmasculine people, testosterone therapy usually stops menstruation as a welcomed side effect of masculinizing hormone therapy. A study of 74 transgender men starting intramuscular testosterone found that about 5% stopped menstruating within the first month, half achieved cessation within two to six months, and roughly a third took longer than six months.12PubMed Central. The Response of the Menstrual Cycle to Initiation of Hormonal Therapy in Transgender Men About 12% in that study needed additional progesterone because their periods hadn’t stopped after a year.
The route of testosterone delivery matters. A study of people using testosterone for gender-affirming care found that those using gels or creams had dramatically higher odds of persistent menstruation beyond six months compared to those using injections.13PubMed Central. Persistent menstruation in transgender people using testosterone gender-affirming hormone therapy Nearly 23% of respondents in that study reported persistent bleeding more than six months after starting testosterone. For those who find ongoing menstruation distressing, adding a progestin method (like a hormonal IUD or norethindrone acetate) alongside testosterone is a common clinical strategy while waiting for testosterone to fully suppress the cycle.
Why Breakthrough Bleeding Happens Early On
Nearly every hormonal method that aims to stop periods has an adaptation phase marked by irregular spotting or light bleeding. This is the number-one reason people discontinue these medications before giving them enough time to work. Understanding why it happens can make the adjustment period easier to tolerate.
When continuous progestin exposure thins the uterine lining, the tissue can become fragile. Small blood vessels in the endometrium grow unstable, and the lining sheds in unpredictable fragments rather than in a single coordinated event. Research has linked this irregular shedding to changes in enzymes that affect clot breakdown in the endometrium, and to inflammatory signaling molecules that increase in users experiencing breakthrough bleeding.14PubMed. A potential mechanism of breakthrough bleeding associated with progestin: involvement in alteration of endometrial endothelial cells Studies of progestin-only implant users have confirmed that inflammatory markers in the uterus are elevated in those with irregular bleeding compared to those who become amenorrheic.15PubMed. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy
The practical takeaway is that early spotting doesn’t mean the method is failing. Most clinicians recommend committing to at least three to six months before evaluating whether a method will achieve acceptable bleeding control. For people who find the spotting intolerable, short courses of supplemental estrogen or brief hormone-free intervals (depending on the method) are sometimes used to stabilize the lining during the transition.
Medications That Reduce but Won’t Stop Periods
Two commonly discussed medications deserve mention because people sometimes expect them to stop periods entirely, when they really just reduce menstrual blood loss. Tranexamic acid, an antifibrinolytic drug, reduces menstrual bleeding by about 26% to 60% by helping blood clot more effectively in the uterus.16PubMed Central. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety It’s taken only during the days of your period and doesn’t affect the hormonal cycle at all.
NSAIDs like ibuprofen and naproxen also reduce menstrual flow, though they’re less effective than tranexamic acid or hormonal methods. A Cochrane review confirmed that NSAIDs outperform placebo for heavy menstrual bleeding but fall short of tranexamic acid, danazol, or the hormonal IUD.17PubMed Central. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding If your goal is a lighter, more manageable period rather than no period at all, these are reasonable non-hormonal options. If you want complete cessation, you’ll need one of the hormonal methods discussed earlier.
How Quickly Fertility Returns After Stopping
A common worry is that medications that stop your period might permanently affect fertility. For nearly all methods, fertility returns after discontinuation, though the timeline varies. The hormonal IUD and the implant have the fastest return: most people ovulate within weeks of removal. Continuous oral contraceptives also clear the system quickly, with ovulation typically returning within one to two cycles.
Depo-Provera is the outlier. An older but frequently cited study found that the median delay to conception after the last injection was about nine months, accounting for the residual duration of the drug’s effect.18PubMed. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand That doesn’t mean fertility is impaired, just delayed. Women trying to conceive soon should keep this timeline in mind when choosing a suppression method. GnRH medications also see a rapid return of hormonal cycling once stopped, usually within four to eight weeks, since they don’t have a depot effect lingering in the body.
Medical Reasons to Suppress Menstruation
Period suppression isn’t only a lifestyle preference. For many people, it’s a medical treatment. Endometriosis and uterine fibroids are two of the most common conditions where stopping menstrual cycling directly reduces disease-related symptoms. GnRH antagonists like relugolix improve heavy menstrual bleeding from fibroids and reduce the pelvic pain associated with endometriosis.11PubMed Central. Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis People with severe anemia from heavy periods, those with bleeding disorders, and individuals with menstrual-related mood disorders may all benefit from suppression.
There’s also a growing recognition that menstruation is not medically necessary when you’re using hormonal contraception. A survey found that only 7% of healthcare providers thought it was physically necessary to have a period every month, and about a third of women surveyed said they’d choose never to menstruate if given the option.19PubMed. Women’s and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives The withdrawal bleed during a placebo week on the pill isn’t a real period in a physiological sense. It’s a response to hormone withdrawal, and skipping it doesn’t cause the uterine lining to build up dangerously, since continuous hormones keep the lining thin.
Choosing Based on Your Priorities
The “best” medication depends on what you’re optimizing for. If you want the highest probability of complete amenorrhea and can tolerate a systemic hormone, Depo-Provera or GnRH medications have the strongest track records for full suppression. If you want a long-acting method with minimal daily effort and can accept that amenorrhea is possible but not guaranteed, the hormonal IUD and implant are strong choices. If you value flexibility and the ability to stop at any time with rapid fertility return, continuous oral contraceptives or high-dose oral progestins make more sense.
Side effect profiles differ meaningfully across these options. Estrogen-containing methods carry a small increased risk of blood clots and aren’t suitable for everyone. Depo-Provera’s bone density concern is real but reversible. GnRH drugs need add-back therapy for safe long-term use. Progestin-only options avoid estrogen-related risks but can cause mood changes, acne, or weight shifts in some people. Having a frank conversation with a clinician about your medical history, timeline, and how important complete cessation (versus just lighter periods) is to you will narrow the field considerably.
When Period Suppression Doesn’t Work as Expected
Persistent bleeding despite being on a suppressive medication is more common than most people realize, and it doesn’t always mean something is wrong. Body weight, baseline bleeding patterns, and whether you were using another hormonal method before switching all influence how quickly and completely you achieve amenorrhea. In the adolescent implant study, prior hormonal contraceptive use and early onset of amenorrhea were among the strongest predictors of continued suppression at one year.4PubMed. Amenorrhea in adolescents using the etonogestrel contraceptive implant In gender-affirming testosterone therapy, the delivery method mattered enormously, with gels performing far worse than injections for menstrual suppression.13PubMed Central. Persistent menstruation in transgender people using testosterone gender-affirming hormone therapy
If bleeding persists beyond six months on any method, it’s worth revisiting the approach rather than assuming the medication simply doesn’t work for you. Dose adjustments, switching delivery routes, or layering a second agent on top of the first are all strategies clinicians use. Sometimes structural causes like polyps or fibroids are responsible for breakthrough bleeding and need their own evaluation. The goal of no periods is achievable for most people, but it sometimes requires patience, troubleshooting, or a combination of methods rather than a single prescription.